Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Companion Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 “Next Generation” Sequencing (NGS)
1.2.4 Fluorescence In Situ Hybridization (FISH)
1.2.5 Immunohistochemistry (IHC)
1.3 Market by Application
1.3.1 Global Cancer Companion Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Companion Diagnostic Market Perspective (2018-2033)
2.2 Cancer Companion Diagnostic Growth Trends by Region
2.2.1 Global Cancer Companion Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Companion Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Cancer Companion Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Cancer Companion Diagnostic Market Dynamics
2.3.1 Cancer Companion Diagnostic Industry Trends
2.3.2 Cancer Companion Diagnostic Market Drivers
2.3.3 Cancer Companion Diagnostic Market Challenges
2.3.4 Cancer Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Companion Diagnostic Players by Revenue
3.1.1 Global Top Cancer Companion Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Cancer Companion Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Companion Diagnostic Revenue
3.4 Global Cancer Companion Diagnostic Market Concentration Ratio
3.4.1 Global Cancer Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Companion Diagnostic Revenue in 2022
3.5 Cancer Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Cancer Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Cancer Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Companion Diagnostic Breakdown Data by Type
4.1 Global Cancer Companion Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Cancer Companion Diagnostic Forecasted Market Size by Type (2024-2033)
5 Cancer Companion Diagnostic Breakdown Data by Application
5.1 Global Cancer Companion Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Cancer Companion Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Companion Diagnostic Market Size (2018-2033)
6.2 North America Cancer Companion Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cancer Companion Diagnostic Market Size by Country (2018-2023)
6.4 North America Cancer Companion Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Companion Diagnostic Market Size (2018-2033)
7.2 Europe Cancer Companion Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cancer Companion Diagnostic Market Size by Country (2018-2023)
7.4 Europe Cancer Companion Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Companion Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific Cancer Companion Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Companion Diagnostic Market Size (2018-2033)
9.2 Latin America Cancer Companion Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cancer Companion Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Cancer Companion Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Companion Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa Cancer Companion Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AmoyDx
11.1.1 AmoyDx Company Detail
11.1.2 AmoyDx Business Overview
11.1.3 AmoyDx Cancer Companion Diagnostic Introduction
11.1.4 AmoyDx Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.1.5 AmoyDx Recent Development
11.2 Novogene
11.2.1 Novogene Company Detail
11.2.2 Novogene Business Overview
11.2.3 Novogene Cancer Companion Diagnostic Introduction
11.2.4 Novogene Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.2.5 Novogene Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Companion Diagnostic Introduction
11.3.4 Illumina Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.3.5 Illumina Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Cancer Companion Diagnostic Introduction
11.4.4 Roche Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Agilent
11.5.1 Agilent Company Detail
11.5.2 Agilent Business Overview
11.5.3 Agilent Cancer Companion Diagnostic Introduction
11.5.4 Agilent Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.5.5 Agilent Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Cancer Companion Diagnostic Introduction
11.6.4 Abbott Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Cancer Companion Diagnostic Introduction
11.7.4 Thermo Fisher Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.7.5 Thermo Fisher Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Detail
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Cancer Companion Diagnostic Introduction
11.8.4 Qiagen Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.8.5 Qiagen Recent Development
11.9 Guardant Health
11.9.1 Guardant Health Company Detail
11.9.2 Guardant Health Business Overview
11.9.3 Guardant Health Cancer Companion Diagnostic Introduction
11.9.4 Guardant Health Revenue in Cancer Companion Diagnostic Business (2018-2023)
11.9.5 Guardant Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of “Next Generation” Sequencing (NGS)
Table 4. Key Players of Fluorescence In Situ Hybridization (FISH)
Table 5. Key Players of Immunohistochemistry (IHC)
Table 6. Global Cancer Companion Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cancer Companion Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cancer Companion Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Companion Diagnostic Market Share by Region (2018-2023)
Table 10. Global Cancer Companion Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Cancer Companion Diagnostic Market Share by Region (2024-2033)
Table 12. Cancer Companion Diagnostic Market Trends
Table 13. Cancer Companion Diagnostic Market Drivers
Table 14. Cancer Companion Diagnostic Market Challenges
Table 15. Cancer Companion Diagnostic Market Restraints
Table 16. Global Cancer Companion Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Companion Diagnostic Market Share by Players (2018-2023)
Table 18. Global Top Cancer Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Companion Diagnostic as of 2022)
Table 19. Ranking of Global Top Cancer Companion Diagnostic Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cancer Companion Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Companion Diagnostic Product Solution and Service
Table 23. Date of Enter into Cancer Companion Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Companion Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Companion Diagnostic Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Companion Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Cancer Companion Diagnostic Revenue Market Share by Type (2024-2033)
Table 29. Global Cancer Companion Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Companion Diagnostic Revenue Market Share by Application (2018-2023)
Table 31. Global Cancer Companion Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Cancer Companion Diagnostic Revenue Market Share by Application (2024-2033)
Table 33. North America Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Cancer Companion Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cancer Companion Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Cancer Companion Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cancer Companion Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Cancer Companion Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Cancer Companion Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cancer Companion Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 48. AmoyDx Company Detail
Table 49. AmoyDx Business Overview
Table 50. AmoyDx Cancer Companion Diagnostic Product
Table 51. AmoyDx Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 52. AmoyDx Recent Development
Table 53. Novogene Company Detail
Table 54. Novogene Business Overview
Table 55. Novogene Cancer Companion Diagnostic Product
Table 56. Novogene Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 57. Novogene Recent Development
Table 58. Illumina Company Detail
Table 59. Illumina Business Overview
Table 60. Illumina Cancer Companion Diagnostic Product
Table 61. Illumina Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 62. Illumina Recent Development
Table 63. Roche Company Detail
Table 64. Roche Business Overview
Table 65. Roche Cancer Companion Diagnostic Product
Table 66. Roche Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Agilent Company Detail
Table 69. Agilent Business Overview
Table 70. Agilent Cancer Companion Diagnostic Product
Table 71. Agilent Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 72. Agilent Recent Development
Table 73. Abbott Company Detail
Table 74. Abbott Business Overview
Table 75. Abbott Cancer Companion Diagnostic Product
Table 76. Abbott Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Thermo Fisher Company Detail
Table 79. Thermo Fisher Business Overview
Table 80. Thermo Fisher Cancer Companion Diagnostic Product
Table 81. Thermo Fisher Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Recent Development
Table 83. Qiagen Company Detail
Table 84. Qiagen Business Overview
Table 85. Qiagen Cancer Companion Diagnostic Product
Table 86. Qiagen Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 87. Qiagen Recent Development
Table 88. Guardant Health Company Detail
Table 89. Guardant Health Business Overview
Table 90. Guardant Health Cancer Companion Diagnostic Product
Table 91. Guardant Health Revenue in Cancer Companion Diagnostic Business (2018-2023) & (US$ Million)
Table 92. Guardant Health Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Companion Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cancer Companion Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. “Next Generation” Sequencing (NGS) Features
Figure 5. Fluorescence In Situ Hybridization (FISH) Features
Figure 6. Immunohistochemistry (IHC) Features
Figure 7. Global Cancer Companion Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Cancer Companion Diagnostic Market Share by Application: 2022 VS 2033
Figure 9. Lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Cancer Companion Diagnostic Report Years Considered
Figure 14. Global Cancer Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Cancer Companion Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Cancer Companion Diagnostic Market Share by Region: 2022 VS 2033
Figure 17. Global Cancer Companion Diagnostic Market Share by Players in 2022
Figure 18. Global Top Cancer Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Companion Diagnostic as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Companion Diagnostic Revenue in 2022
Figure 20. North America Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Cancer Companion Diagnostic Market Share by Country (2018-2033)
Figure 22. United States Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cancer Companion Diagnostic Market Share by Country (2018-2033)
Figure 26. Germany Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cancer Companion Diagnostic Market Share by Region (2018-2033)
Figure 34. China Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cancer Companion Diagnostic Market Share by Country (2018-2033)
Figure 42. Mexico Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cancer Companion Diagnostic Market Share by Country (2018-2033)
Figure 46. Turkey Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Cancer Companion Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. AmoyDx Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 49. Novogene Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 50. Illumina Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 52. Agilent Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 54. Thermo Fisher Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 55. Qiagen Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 56. Guardant Health Revenue Growth Rate in Cancer Companion Diagnostic Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed